Trump administration announces funding for PTSD research on ibogaineWIRED investigation examines Jensen Huang's comments on defining women's power in techWalmart launches early Black Friday promotions on select giftsMint Mobile offers $500 discount on select new phones for new customers signing up for a yearRussia and Iran criticize U.S. Caspian task force amid reports of joint sanction evasion effortsNewly elected US lawmakers pose for traditional group photo at Capitol ahead of 120th Congress openingUS existing home sales drop to lowest monthly level in yearsPro-Palestine philanthropist faces US extradition hearing in SpainLewisham Islamic Centre criticizes charity watchdog over warning on Palestine commentsSenegalese wrestlers succeed in beach wrestling at Dakar Youth OlympicsUS nonprofits file lawsuit seeking pause on advanced AI model trainingDemocrats convene in Denver to discuss party direction after midterm victoriesUS releases report on $12bn from Venezuelan oil, mineral resourcesPope Leo XIV urges Catholic Church to address clergy sexual abuseShooting near White House results in death, suspect later found dead
All fact checks
AI analysis

Fact check

“ProPublica used the DUNS number to collect data for Rx Inspector.”
VerifiedConfidence: HIGH

Reasoning

The provided evidence directly quotes ProPublica describing the use of the DUNS (unique facility identification) number to gather data for the Rx Inspector tool, confirming the claim.

On confidence: Multiple excerpts from the same ProPublica article explicitly state that ProPublica used the DUNS number to collect data for Rx Inspector.

Important context

The DUNS number is a unique facility identifier that can link generic drugs to specific manufacturing sites, and ProPublica leveraged this identifier in building Rx Inspector.

Evidence

Supporting (4)

Limitations

All evidence comes from a single ProPublica article; no independent third‑party sources are provided to corroborate the statement.

Last verified:
Sep 27, 2026, 4:24 AM CDT
Pipeline:
2.1.0
Claim type:
Factual

Where this claim appeared

“A Clear Watering Down”: Drug Transparency Bill Stripped of Critical Provisions Ahead of Senate Vote

ProPublica · Naisha Roy